Sanofi SA (SASY)

89.33
+0.55(+0.62%)
  • वॉल्यूम:
    3,085
  • बोली/पुछे:
    89.33/89.34
  • दिन की रेंज:
    88.99 - 89.68

SASY समीक्षा

पिछला बंद
88.78
दिन की रेंज
88.99-89.68
आय
-
खुला
89.08
52 सप्ताह रेंज
76.45-106.08
ईपीएस
-
वॉल्यूम
3,085
मार्केट कैप
111.44B
लाभांश (यील्ड)
N/A
(N/A)
औसत वॉल्यूम (3एम)
6,426
पी/ई अनुपात
16.64
बीटा
-
1- वर्ष बदलाव
-4.87%
बकाया शेयर
1,247,405,732
अगली कमाई तिथि
26 अप्रैल 2023
Sanofi पर आपकी भावना क्या है?
या
समुदाय परिणामों को देखने के लिए वोट करें!

Sanofi SA समाचार

Sanofi SA विश्लेषण

Sanofi SA कंपनी प्रोफाइल

Sanofi SA कंपनी प्रोफाइल

क्षेत्र
हेल्थकेयर
कर्मचारी
95442
बाज़ार
फ्रांस
  • प्रकार:इक्विटी
  • बाज़ार:जर्मनी
  • आईसआईन:FR0000120578
  • डब्लूकेन:920657

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

और पढ़ें

विश्लेषक मूल्य लक्ष्य

औसत102.73 (+15.06% ऊपर)
उच्च128.00
निम्न57.4393
क़ीमत89.28
विश्लेषकों की संख्या24
मजबूत विक्रय
बेचना
तटस्थ
खरीदें
मजबूत खरीद
खरीदें
विश्लेषकों की आम सहमति

तकनीकी सारांश

प्रकार
5 मिनट
15 मिनट
प्रति घंटा
दैनिक
मासिक
मूविंग एवरेजतटस्थखरीदेंखरीदेंमजबूत खरीदमजबूत खरीद
तकनीकी संकेतकबेचनातटस्थमजबूत खरीदखरीदेंतटस्थ
सारांशतटस्थतटस्थमजबूत खरीदमजबूत खरीदखरीदें